Early evidence links some Alzheimer’s Disease medications to small cognitive gains in children with autism and low IQ, ...
Background To address escalating opioid-related harm, an Australian evidence-based guideline for deprescribing opioids was ...
The Alzheimer’s drugs market is projected to grow at a compound annual growth rate (CAGR) of approximately 20% during the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results